GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQTM (GS010) compared to LHON natural history
(WorldNews France)

GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQTM (GS010) compared to LHON natural history 11 Dec 2019 07:30 CET Company Name GENSIGHT BIOLOGICS ISN FR0013183985 Market Euronext Symbol SIGHT Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191210006078/en/ Figure 1. LHON Natural History from Interim Analysis of REALITY vs. Time Course of Visual Acuity from REVERSE and RESCUE - Note: BCVA = best-corrected visual acuity. The LOWESS line for REALITY (n=15 subjects) is based on a series of polynomial regressions around each data point. The...